Are alpha-glucosidase inhibitors effective for control of type 2 diabetes?

American Family Physician

Volumn 73, Issue 3, 2006, Pages

  Brewer, Dan ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GLUCOSIDASE INHIBITOR; BIGUANIDE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; INSULIN; METFORMIN; SULFONYLUREA;

DIABETES CONTROL; DIARRHEA; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; ENZYME INHIBITION; FLATULENCE; GASTROINTESTINAL SYMPTOM; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; METABOLIC DISORDER; MONOTHERAPY; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; QUALITY OF LIFE; REVIEW;

ALPHA-GLUCOSIDASES; DIABETES MELLITUS, TYPE 2; ENZYME INHIBITORS; HUMANS; RANDOMIZED CONTROLLED TRIALS;

EID: 32244437637     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (5)

1. Van de Laar FA, Lucassen PL, Akkermans RP, Van de Lisdonk EH, Rutten GE, Van Weel C. Alpha-glucosidase inhibitors for type 2 diabetes mellitus. Cochrane Database Syst Rev 2005;(2):CD003639.
2. IDF Clinical Guidelines Task Force. Global guideline for type 2 diabetes. Brussels: International Diabetes Federation, 2005.
3. Inzucchi SE. Oral antihyperglycemic therapy for type 2 diabetes: scientific review. JAMA 2002;287:360-72.
4. Holman RR, Cull CA, Turner RC. A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44) [published correction appears in Diabetes Care 1999;22:1922]. Diabetes Care 1999;22:960-4.
5. U.K. Prospective Diabetes Study Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (U.K. Prospective Diabetes Study 34) [published correction appears in Lancet 1998;352:1557]. Lancet 1998;352:854-65.